Literature DB >> 17200716

Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.

Christopher Jones1, Rita Garuti, Peter Michaely, Wei-Ping Li, Nobuyo Maeda, Jonathan C Cohen, Joachim Herz, Helen H Hobbs.   

Abstract

Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr(-/-)) and ARH (Arh(-/-)). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh(-/-) mice compared with Ldlr(-/-) mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh(-/-) mice than in Ldlr(-/-) mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh(-/-) mice (but not Ldlr(-/-) mice) internalized beta-migrating VLDL (beta-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200716      PMCID: PMC1716209          DOI: 10.1172/JCI29415

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Measurement of nanogram quantities of protein by hydrolysis followed by reaction with orthophthalaldehyde or determination of glutamate.

Authors:  E C Butcher; O H Lowry
Journal:  Anal Biochem       Date:  1976-12       Impact factor: 3.365

2.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.

Authors:  T L Innerarity; R W Mahley
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

3.  The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits.

Authors:  Rita Garuti; Christopher Jones; Wei-Ping Li; Peter Michaely; Joachim Herz; Robert D Gerard; Jonathan C Cohen; Helen H Hobbs
Journal:  J Biol Chem       Date:  2005-09-22       Impact factor: 5.157

4.  Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein.

Authors:  R E Pitas; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

5.  Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells.

Authors:  M Krieger; L C Smith; R G Anderson; J L Goldstein; Y J Kao; H J Pownall; A M Gotto; M S Brown
Journal:  J Supramol Struct       Date:  1979

6.  Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin.

Authors:  M J Imber; S V Pizzo
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

7.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.

Authors:  P T Kovanen; M S Brown; S K Basu; D W Bilheimer; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Normal production rate of apolipoprotein B in LDL receptor-deficient mice.

Authors:  John S Millar; Cyrille Maugeais; Ilia V Fuki; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

10.  Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy.

Authors:  R E Pitas; T L Innerarity; J N Weinstein; R W Mahley
Journal:  Arteriosclerosis       Date:  1981 May-Jun
View more
  26 in total

1.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Science, serendipity, and the single degree.

Authors:  Helen H Hobbs
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

3.  Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.

Authors:  John Zhong Li; Yongcheng Huang; Ruchan Karaman; Pavlina T Ivanova; H Alex Brown; Thomas Roddy; Jose Castro-Perez; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

Review 4.  The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

Authors:  Geesje M Dallinga-Thie; Remco Franssen; Hans L Mooij; Maartje E Visser; H Carlijne Hassing; Frank Peelman; John J P Kastelein; Miklós Péterfy; Max Nieuwdorp
Journal:  Atherosclerosis       Date:  2009-12-29       Impact factor: 5.162

Review 5.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

6.  The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.

Authors:  Leslie G Biesecker; James C Mullikin; Flavia M Facio; Clesson Turner; Praveen F Cherukuri; Robert W Blakesley; Gerard G Bouffard; Peter S Chines; Pedro Cruz; Nancy F Hansen; Jamie K Teer; Baishali Maskeri; Alice C Young; Teri A Manolio; Alexander F Wilson; Toren Finkel; Paul Hwang; Andrew Arai; Alan T Remaley; Vandana Sachdev; Robert Shamburek; Richard O Cannon; Eric D Green
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

7.  Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.

Authors:  Pin Yue; Zhouji Chen; Fatiha Nassir; Carlos Bernal-Mizrachi; Brian Finck; Salman Azhar; Nada A Abumrad
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

8.  Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB.

Authors:  Daniel A Blasiole; Angie T Oler; Alan D Attie
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

9.  The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney.

Authors:  Liang Fang; Rita Garuti; Bo-Young Kim; James B Wade; Paul A Welling
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

10.  Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.

Authors:  Michael Altenburg; Jose Arbones-Mainar; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-27       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.